Riken In-House Probe Fails To Confirm Controversial STAP Studies
This article was originally published in PharmAsia News
Executive Summary
Japan's Riken Institute issued an apology and a report that said its in-house investigation was unable to find the answers to all the questions raised about a controversial stem-cell study published in January.